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a b s t r a c t
Background:Restingplasmanorepinephrine (NE) levelwas reportedly related tohighmortality inpatients
with heart failure. The current study investigated whether resting NE could predict long-term major
adverse cerebral and cardiovascular events (MACCEs) in Japanese type 2 diabetic patients without heart
disease.
Methods and subjects: We evaluated resting NE in 95 patients with type 2 diabetes who did not have
severe complications. Based on the ROC curves, high NE was deﬁned as ≥333pg/ml. Accurate follow-up
information during a mean of 3.6±1.9 years was obtained in 27 high NE patients (13 female, mean age
64±12 years) and 68 low NE patients (29 female, 60±12 years).
Essential results: The Kaplan–Meier curves revealed that MACCE-free ratio was signiﬁcantly lower in
the high NE patients than in the low NE patients (log-rank 10.3, p=0.0013). Cox proportional hazards
regression analysis revealed that female gender (hazard ratio 7.75), low baroreﬂex sensitivity (hazard
ratio 6.66), and high NE (hazard ratio 5.40) were independently associated with the incidence of MACCE.
Principal conclusions: Our results suggest that resting NE is comparably useful to identify the high-risk
patients for MACCE to baroreﬂex sensitivity in type 2 diabetic patients. The results also suggest that
pathogenic sympathetic activation leading to MACCE may be identiﬁed by the assessment of resting NE,
more easily and less expensively compared to cardiac iodine 123 metaiodobenzylguanidine scintigraphy
in this population.
© 2ntroduction
The autonomic imbalance, characterized by increased sym-
athetic activity and/or decreased parasympathetic activity, is
ightly related to cardiovascular mortality. In our series of clin-
cal studies investigating baroreﬂex sensitivity (BRS) in patients
ith type 2 diabetes mellitus without structural heart disease
1–5], the presence of essential hypertension [1], microalbumin-
ria [2], high levels of high-sensitivity C-reactive protein [3],
rain natriuretic peptide [4], hypoadiponectinemia [5], or major
dverse cerebral and cardiovascular events (MACCEs) [6] have been
ssociated with low levels of BRS. On the other hand, cardiac
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adrenergic nerve activity has been estimated by use of iodine 123
metaiodobenzylguanidine (123I-MIBG) as a noradrenaline analog
[7,8]. In the previous study, we demonstrated that the abnor-
mally increased washout ratio (WR) of cardiac 123I-MIBG at
baseline has long-term cardiovascular predictive value in Japanese
patients with type 2 diabetes without structural heart disease
[9].
A previous Studies of Left Ventricular Dysfunction (SOLVD)
trial indicated that patients with asymptomatic left ventricular
dysfunction had early increases in plasma norepinephrine (NE),
renin activity, and atrial natriuretic peptide comparedwith healthy
control subjects [10]. There is consistent evidence that high sym-
pathetic tone, as measured by plasma NE, predicts mortality in
chronic heart failure [10,11], whereas in myocardial infarction, this
neurohormone is a weak predictor of adverse outcomes [12]. The
objective of this study is to clarify the predictive value of resting
plasma NE for MACCE in patients with type 2 diabetic patients


























































Plasma NE cut-off values were determined from receiver oper-
ating characteristic curve (Fig. 1). The best plasma NE with the
highest sensitivity and speciﬁcity to predictMACCEwas 333pg/ml.
Therefore, we deﬁned high NE patients as ≥333pg/ml. From 1998,26 K. Yufu et al. / Journal of
aterials and methods
atient selection
A total of 210 patients with type 2 diabetes mellitus, who were
dmitted to Oita University Hospital from 1998 to 2004 for blood
lucose control were recruited. Plasma NE was measured in the
asting and resting states in the supine position early in the morn-
ng. One hundred nineteen patients (68men and 51women) of 210
atients had plasma NE measured and conﬁrmed retrospectively.
ollow-up data were obtained in 95 patients (80%).
Type 2 diabetes mellitus was deﬁned as a fasting plasma
lucose concentration ≥126mg/dl, a 2h plasma glucose con-
entration following a 75g oral glucose load ≥200mg/dl, or
he self-reported use of antidiabetic medication [13]. None of
he patients had organic heart disease as determined by physi-
al examinations, chest X-ray, 12-lead electrocardiogram (ECG),
chocardiography, and 201thallium SPECT. Myocardial ischemia
as excluded by treadmill exercise ECG testing and 201thallium
PECT. Essential hypertension was deﬁned as diastolic blood pres-
ure (BP) ≥90mmHg, systolic BP ≥140mmHg or self-reported use
f antihypertensive medication [14]. Patients treated with alpha-
r beta-adrenergic blocking agents, tricyclic antidepressants or
ther serotonin reuptake inhibitors, anti-platelet agents or with
acroalbuminuria (≥500mg/day), or abnormal plasma creatinine
oncentrations (≥1.2mg/dl) were also excluded from the study.
yslipidemia was deﬁned as fasting triglycerides >200mg/dl, or
igh-density lipoprotein (HDL) cholesterol ≤45mg/dl in women
nd ≤35mg/dl in men [15]. Hyperuricemia was deﬁned as uric
cid >6.0mg/dl in women or >7.0mg/dl in men [16]. Chronic
idney disease (CKD) was deﬁned as an estimated glomerular
ltration rate (e-GFR) <60ml/min/1.73m2 [17]. Patients with an e-
FR <30ml/min/1.73m2 were excluded. The hemoglobin (Hb) A1c
alue was determined by Japan Diabetes Society (JDS) method.
This investigation was conducted according to the principles
xpressed in the Declaration of Helsinki. Prior informed consent
n terms of gathering BRS measurements was obtained from all
atients, and the study protocol was approved by the institutional
eview board of Oita University.
ardiac 123I-MIBG scintigraphy
Planar studies were performed at 15min (early) and 4h
delayed) after the injection of 111MBq of 123I-MIBG using a rotat-
ng gamma camera equipped with a low-energy, parallel-hole,
ll-purpose collimator (ZLC 7500; Siemens, Munich, Germany).
ata were analyzed with computer-based analysis software
SCINTIPAC; Shimadzu, Kyoto, Japan). The anterior planar images
f the early and delayed 123I-MIBG studies were analyzed visually.
or semiquantitative analysis, the mean heart count per pixel
H) was calculated. Another region of interest was placed at a
0mm×10mm area over the upper mediastinum, and the mean
ediastinum count per pixel (M) was calculated. The H/M ratio
as calculated from early and delayed anterior planar images
1,18]. After correcting for the physical decay of 123I-MIBG,
he percentage WR of the tracer from the myocardium was
etermined for the 4-h period. The WR was calculated from the
nitial and delayed images using the following formula without
orrection for the background and the time decay of 123I label:
[(H)− (M)]early− [(H)− (M)]delayed)×100/[(H)− (M)]early (%),
s previously reported [1,18]. In our hospital, the normal ranges
f early H/M ratio, delayed H/M ratio, and WR were set at 2.0–2.7,
.1–2.9, and 21–30%, respectively.
We deﬁned enhanced WR and depressed delayed H/M ratio as
41.4% and ≤1.89, respectively, as we previously reported [19].logy 64 (2014) 225–230
BRS measurements
ForBRSassessment, all subjectswere studiedwhile in the supine
position in aquiet roombetween09:00hand11:00h [1]. A catheter
was inserted into the right cubital vein, and arterial blood pres-
sure was recorded noninvasively using tonometry (Jentow-7700;
Nihon Colin, Komaki, Japan) [1]. Arterial blood pressure and a 12-
lead ECG were monitored simultaneously. Data were stored in a
PCM data recorder (RD-200T; TEAC, Tokyo, Japan). After an inter-
val of 30min to allow the patient to stabilize, the patient was
asked to breathe at a rate of 15breaths/min using a metronome.
BRS was assessed using the phenylephrine method [14]. Phenyle-
phrine (2–3g/kg)was injected over 15 s to increase systolic blood
pressure by 15–40mmHg. BRS was calculated as the slope of the
linear regression line relating the systolic blood pressure changes
to the RR interval changes. Regression lines with more than 20
data points and a correlation coefﬁcient (r) greater than 0.8 were
accepted for analysis [6,14].We deﬁned depressed BRS as the value
≤5.63ms/mmHg, as we previously reported [19].
Follow-up
Most of the follow-up for patients occurred at our hospital (Oita
UniversityHospital). Informationwas obtained from those patients
whose follow-upwasperformedbyageneral practitioner. Informa-
tion on the patients who were hospitalized in other departments
was also obtained. For the patients who died, the cause of death
was documented with the help of the patients’ family and general
practitioners.
An end point was deﬁned as the appearance of MACCE, which
included cardiovascular mortality, nonfatal myocardial infarction,
coronary revascularization through angioplasty or bypass, stroke,
and congestive heart failure requiring admission. Using this com-
bined criterion, only the ﬁrst event was taken into account in
statistical analysis.Fig. 1. Receiver-operating characteristic curve for the ability of resting plasma nor-







































MACCEs are presented in Table 3. The univariate analysis revealed
that female gender, hyperuricemia, e-GFR, low BRS, and high NE
were associated with the MACCE. On the following multivariate
analysis using risk factors including female gender, body massK. Yufu et al. / Journal of
ccurate follow-up information for 3.6±1.9 years was obtained in
7 highNE patients (13 female,mean age 64±12 years) and 68 low
E patients (29 female, 60±12 years).
tatistical analysis
Data are presented as mean± SD. The chi-square test was used
or categorical variables, and the analysis of variance (ANOVA)
est was used for continuous variables. Kaplan–Meier MACCE-free
nalysis was used to compare MACCE-free times between the
igh NE group and the low NE group. Univariate and multivari-
te Cox proportional hazard regression analyses were performed
o identify independent predictors (risk factors) of the MACCE. Risk
actors entered into the riskmodel included age, gender, bodymass
ndex, smoking status, duration of diabetes, fasting plasma glu-
ose, hemoglobin A1c, hypertension, dyslipidemia, hyperuricemia,
-GFR. Results are given as hazard ratioswith 95% conﬁdence inter-
als. A value of p<0.05was considered signiﬁcant.Multivariate Cox
egression analysis was performed only for variables with signiﬁ-
ant univariate impact. All computationswere performedwith JMP
JMP version 9.0.0, SAS, Cary, NC, USA), running under Windows 7
Microsoft, Redmond, WA, USA).
esults
atient characteristics
Baseline patient characteristics of high and low NE patients
re presented in Table 1. The delayed H/M ratio (p<0.05) and
he resting plasma NE (p<0.0001) were higher in the high NE
atients than in the low NE patients. No signiﬁcant difference was
bserved in terms of age, body mass index, duration of diabetes,
asting plasma glucose, or HbA1c, total cholesterol, triglyceride,
igh-density lipoprotein cholesterol, uric acid, creatinine, blood
ressure, heart rate, or e-GFR. There was no difference between
roups with regard to gender, current smoking, hypertension, dys-
ipidemia, or hyperuricemia. Regarding drug use, no signiﬁcant
able 1
linical characteristics of studied patients.
High NE Low NE p-Value
(n=27) (n=68)
Age (years) 64±12 60±12 NS
Gender (female/male) 13/14 29/39 NS
Body mass index (kg/m2) 26±6 24±5 NS
Current smoker (%) 56 53 NS
Duration of diabetes (years) 9±7 10±9 NS
Fasting plasma glucose (mg/dl) 143±47 160±47 NS
Hemoglobin A1c (JDS) (%) 7.7±1.5 8.3±1.7 NS
Total cholesterol (mg/dl) 193±34 204±50 NS
Triglyceride (mg/dl) 134±65 157±183 NS
HDL cholesterol (mg/dl) 48±16 46±14 NS
Uric acid (mg/dl) 5.6±1.7 5.3±1.6 NS
Creatinine (mg/dl) 0.8±0.3 0.8±0.4 NS
Hypertension (%) 67 66 NS
Systolic BP (mmHg) 135±19 129±23 NS
Diastolic BP (mmHg) 71±12 69±14 NS
Heart rate (beats/min) 69±9 70±9 NS
Dyslipidemia (%) 81 75 NS
Hyperuricemia (%) 33 26 NS
e-GFR (ml/min/1.73m2) 77±28 78±29 NS
WR (%) 35±10 40±14 NS
Delayed H/M ratio 2.4±0.7 2.1±0.4 <0.05
BRS (ms/mmHg) 7.1±4.9 7.0±4.9 NS
Resting plasma NE (pg/ml) 427±84 199±68 <0.0001
ata are mean± SD.
P, blood pressure; BRS, baroreﬂex sensitivity; e-GFR, estimated glomerular ﬁltra-
ion rate; HDL, high-density lipoprotein; H/M, heart-to-mediastinum; JDS, Japan
iabetes Society; NE, norepinephrine; WR, washout ratio.logy 64 (2014) 225–230 227
differences between the 2 groups were observed in percentage of
the patients who were being treated with angiotensin II receptor
blockers, angiotensin-converting enzyme inhibitors, calcium chan-
nel blockers, beta blockers, or statins.
Patient outcomes
During the follow-up, 2 patients died (2%). Of the 2 deaths, one
was cardiac death, while the other was attributed to non-cardiac
causes. All causes of mortality were not signiﬁcantly different
between the high NE patients and the low NE patients. There were
no signiﬁcant differences in total cardiac mortalities between the
2 groups.
MACCE-free estimation
MACCE-free ratio as evaluated by Kaplan–Meier analysis was
signiﬁcantly lower in the high NE patients than in the low NE
patients (log-rank 10.3, p=0.0013) (Fig. 2).
Univariate and multivariate predictors of MACCE
During the follow-up, 10 patients presented with MACCE
(11.0%). Of the 11 MACCEs, 1 was attributed to cardiac death, 0
wereattributed tononfatalmyocardial infarctions, 1wasattributed
to coronary revascularizations, 5 were attributed to strokes, and
3 were attributed to congestive heart failure (Table 2). The MAC-
CEs were observed more frequently in the high NE patients (26%)
than in the lowNE patients (4%, p<0.005). Results of univariate and
multivariate Cox proportional hazards regression analysis of theFig. 2. Kaplan–Meier event-free curves for major adverse cardiac and cerebrovas-
cular events between the high norepinephrine patients and the low norepinephrine
patients. NE, norepinephrine.
Table 2
Number of patients developing MACCE.
High NE Low NE
(n=27) (n=68)
Cardiac death 0 1
Nonfatal myocardial infarction 0 0
Coronary revascularization 1 0
Stroke 5 0
Congestive heart failure 2 1
Total 8 2
MACCE, major adverse cardiac and cerebrovascular events; NE, norepinephrine.
228 K. Yufu et al. / Journal of Cardiology 64 (2014) 225–230
Table 3
Univariate and multivariate association of baseline characteristics with MACCE.
Univariate Multivariate 95% CI p-Value
p-Value Hazard ratio
Age (years) 0.5944
Female gender 0.0154* 7.75 1.41–69.1 0.0172*
Body mass index (kg/m2) 0.0240* 1.04 0.853–1.27 0.6968
Current smoker 0.1069
Duration of diabetes (years) 0.9712
Fasting plasma glucose (mg/dl) 0.8668
Hemoglobin A1c (%) 0.6608
Hypertension (%) 0.5000
Dyslipidemia (%) 0.2194
Hyperuricemia (%) 0.0052** 2.11 0.208–23.5 0.5243
e-GFR (ml/min/1.73 m2) 0.0367* 0.98 0.937–1.01 0.2143
High WR (≥41.4%) 0.4775
Low delayed H/M ratio (≤1.89) 0.1475
Low BRS (≤5.63ms/mmHg) 0.0047** 6.66 1.66–33.0 0.0077**
High NE (≥333pg/ml) 0.0033** 5.40 1.21–29.3 0.0275*
BRS, baroreﬂex sensitivity; CI, conﬁdence interval; e-GFR, estimated glomerular ﬁltration rate; H/M, heart-to-mediastinum; MACCEs, major adverse cardiac and cerebrovas-








































ndex, hyperuricemia, e-GFR, low BRS, and high NE, female gender
hazard ratio 7.75, 95% conﬁdence interval 1.41–69.1, p=0.0172),
ow BRS (hazard ratio 6.66, 95% conﬁdence interval 1.66–33.0,
= 0.0077), and high NE (hazard ratio 5.40, 95% conﬁdence inter-
al 1.21–29.3, p=0.0275) independently predicted the incidence of
ACCE by multivariate analysis (Table 3).
iscussion
In the present study, 95 Japanese type 2 diabetic patients were
ollowed for a mean period of 3.6 years, and MACCE developed
n 11 patients. The most important ﬁnding is that high NE value
an accurately predict cardiovascular events in patients with type
diabetes without structural heart disease/severe complications,
hich is comparable to BRS value. MACCE-free ratio as evaluated
y Kaplan–Meier analysis was signiﬁcantly lower in the high NE
atients than in the low NE patients.
In this study, cardiac sympathetic function was estimated by
wo different methods, including plasma NE concentration and
23I-MIBG scintigraphy. The 123I-MIBG is an analog of guanidine
hat shares the same neuronal transport and storage mecha-
isms with norepinephrine. In the heart, it is considered that
educed uptake of 123I-MIBG (H/M ratio) reﬂects reduced norepi-
ephrine content at presynaptic sits or reduced neural density,
hile an enhanced washout rate of 123I-MIBG reﬂects enhanced
elease of norepinephrine from presynaptic sites [20]. We have
reviously reported in our series of investigations that cardiac
23I-MIBG scintigraphic ﬁndings, such as H/M ratio and WR are
seful to identify high-risk patients [9,19]. However, the current
tudy revealed that resting plasma NE more accurately predicts
ACCE than cardiac 123I-MIBG scintigraphic ﬁndings. Although
he reason is unclear, our results suggest that pathogenic sym-
athetic activation leading to MACCE may be identiﬁed by the
ssessment of resting plasma NE, more easily and less expensively
ompared to cardiac 123I-MIBG scintigraphy. On the other hand,
RS with the phenylephrine method estimates reﬂex cardiovascu-
ar vagal activity. In this study, hazard ratio of low BRS predicting
he incidence of the MACCE by multivariate analysis was greater
han that of high NE. This result might suggest that the analysis
f cardiovascular vagal activity rather than cardiac sympathetic
unction may be more sensitive in risk stratiﬁcation in this pop-
lation.Benedict et al. demonstrated the importance of initial plasma
NE levels as a powerful prognostic predictor for mortality and
morbidity in patients with asymptomatic left ventricular (LV) dys-
function [10]. Elevation in plasma NE levels might contribute to
the progression of the disease syndrome by impairing physiologi-
cal vasodilation [21], adversely affecting cardiac loading through
deleterious effects on myocardial function and structure [22],
and inciting development of ventricular arrhythmias [23]. They
explained that the mechanisms by which an increase in cate-
cholamines might cause ischemic heart events were promotion of
platelet aggregation and platelet thrombi formation [23], increased
myocardial oxygen demand owing to an increase in heart rate, and
predisposition to the development of ventricular arrhythmias [10].
The cut-off value of the plasma NE (393pg/ml) in their study was
higher than ours (333pg/ml). This differencemight be explained by
the severity of the disease condition, i.e. ours included type 2 dia-
betic patients without severe complications while they included
patients with LV dysfunction, and ischemic heart disease (about
90%).
On the other hand, in the Survival and Ventricular Enlarge-
ment (SAVE) Trial, only plasma renin activity and atrial natriuretic
peptide were independently predictive of cardiovascular mortal-
ity, whereas the other neurohormones including plasma NE were
not [12]. It should be further estimated as to which is the bet-
ter predictor between plasma renin activity and plasma NE in our
population.
Martin et al. observed that patients of apical ballooning syn-
drome had abnormal vasoreactivity and sympathetic responses to
acute mental stress testing in the laboratory setting. There was a
signiﬁcant correlation between the percentage change in plasma
NE levels and percentage decrease in endothelial function, as man-
ifested by reactive hyperemia peripheral arterial tonometry score,
after acutemental stress testing in all subjects [24].Watanabe et al.
demonstrated that endothelial function assessed byﬂow-mediated
dilation was well correlated with sympathetic activity evaluated
by the power ratio of low-frequency power to high-frequency
power in the heart rate variability, and autonomic nervous system
activity was an important regulatory factor of endothelial func-
tion in subjects with ischemic heart disease. The ﬁnding that this
interaction was suppressed by beta-blockers and the presence of
diabetes suggests that the autonomic nervous system had an effect
on endothelial function [25]. Taken together, it is suggested that
greater MACCEs in the high NE patients in this study might be
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Someevidence suggested that beneﬁcial effects of beta-blockers
n long-term survival of patients with chronic heart failure could
e contributed to by heart rate reduction. Itwas strongly supported
y the ﬁnding that improvement in survival was closely correlated
ith heart rate reduction but not with the dose of beta-blockers in
eart failure treatment [26,27].
In this study, predictors of MACCE were not only low BRS and
igh NE, but also female gender. Huxley et al. explained why
iabetes had a greater adverse effect in females than in males.
ccording to their analysis, diabetes may induce a more unfavor-
ble cardiovascular risk proﬁle among females. They found that
omen with diabetes not only have signiﬁcantly higher levels of
lood pressure and lipids than males with diabetes but also that
he difference in the levels among people with and without dia-
etes was signiﬁcant greater in females than it was in males [28].
e previously demonstrated that depressed BRS value can accu-
ately predict cardiac cerebrovascular events, especially in female
atientswith type 2 diabetes. Once diabetic, a femalewhodevelops
n impaired BRS has a worse prognosis than a similar male [29].
In this study, it was not clear if the mechanism of the elevated
lasma NE in the high NE patients was associated with autonomic
ysfunction in diabetic patients. At least no signiﬁcant difference
as observed in terms of age, body mass index, duration of dia-
etes, or diabetic control between the high NE patients and the low
E patients. Although the patients with the organic heart disease
s determined by physical examinationswere excluded,we did not
valuate the detailed cardiac diastolic function derived from septal
eak left ventricular relaxation velocity by tissue Doppler. Cardiac
iastolic dysfunction was suggested to be the cause of elevated
lasma NE.
Several limitations should be considered in the present study.
irst, the average age of high NE patients was not matched with
hat of low NE patients. Second, clinical manifestations of diabetic
utonomic neuropathy involve many categories, including car-
iovascular, gastrointestinal, genitourinary,metabolic, sudomotor,
nd papillary. Because we did not quantitatively evaluate other
utonomic neuropathy, the association between plasma NE and
ther systemic autonomic neuropathy remains unclear. Third, we
ouldnotprecisely evaluate serial changesofdiabetic status includ-
ngplasmaglucose level andHbA1cduring follow-up. Finally, in the
revious study, the patients with mild heart failure, whose resting
lasma NE levels were only mildly elevated, exercise plasma con-
entrations could provide prognostic information for cardiac death
30].We did not evaluate exercise plasmaNE concentrations in this
tudy.
onclusion
Our results suggest that resting plasma NE is comparably useful
o identify high-risk patients for MACCE to BRS in type 2 diabetic
atients. The results also suggest that pathogenic sympathetic acti-
ation leading to MACCE may be identiﬁed by the assessment of
esting plasma NE, more easily and less expensively compared to
ardiac 123I-MIBG scintigraphy in this population.
unding
There is no ﬁnancial support for the present study.
uthors’ contributionKunio Yufu analyzed data and wrote and revised/edited the
anuscript; Kunio Yufu, Norihiro Okada, and Yukichi Murozono
rovided patient care and samples, collected data, compiled
atabase; Yuki Ebata, Tetsuji Shinohara, and Mikiko Nakagawa
[
[logy 64 (2014) 225–230 229
supervised the overall study with Naohiko Takahashi, provided
patient care and samples, and revised the manuscript.
References
[1] Takahashi N, Nakagawa M, Saikawa T, Ooie T, Yufu K, Shigematsu S, Hara M,
SakinoH, Katsuragi I, Okeda T, YoshimatsuH, Sakata T. Effect of essential hyper-
tension on cardiac autonomic function in type 2 diabetic patients. J Am Coll
Cardiol 2001;38:232–7.
[2] Takahashi N, Anan F, Nakagawa M, Yufu K, Ooie T, Nawata T, Shigematsu S,
Hara M, Saikawa T, Yoshimatsu H. Microalbuminuria, cardiovascular auto-
nomic dysfunction, and insulin resistance in patients with type 2 diabetes
mellitus. Metabolism 2004;53:1359–64.
[3] Anan F, Takahashi N, Nakagawa M, Yufu K, Ooie T, Nawata T, Shigematsu S,
Hara M, Saikawa T, Yoshimatsu H. High-sensitivity C-reactive protein is associ-
ated with insulin resistance and cardiovascular autonomic dysfunction in type
2 diabetic patients. Metabolism 2005;54:552–8.
[4] Yufu K, Takahashi N, Nakagawa M, Hara M, Saikawa T, Yoshimatsu H. Brain
natriuretic peptide and cardiac autonomic function in type 2 diabetic patients.
Diabetes Res Clin Pract 2006;72:12–9.
[5] Takahashi N, Anan F, Nakagawa M, Yufu K, Shinohara T, Tsubone T,
Goto K, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Hara M, Saikawa T,
Yoshimatsu. Hypoadiponectinemia in type 2 diabetes mellitus in men is
associated with sympathetic overactivity as evaluated by cardiac 123I-
metaiodobenzylguanidine scintigraphy. Metabolism 2007;56:919–24.
[6] Okada N, Takahashi N, Murozono Y, Wakisaka O, Shinohara T, Anan F,
Nakagawa M, Hara M, Saikawa T, Yoshimatsu H. Baroreﬂex sensitivity pre-
dicts cardiovascular events in patients with type 2 diabetes mellitus without
structural heart disease. Circ J 2010;74:1379–83.
[7] Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clinthorne NH,
Otto CA, Swanson DP, Beierwaltes WH. Myocardial imaging with a radioiodi-
nated norepinephrine storage analog. J Nucl Med 1981;22:22–31.
[8] Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, Ugolini V,
Akers MS, Hansen C, Buja LM, Parkey RW, Willerson JT. Abnormal I-123
metaiodobenzylguanidine myocardial washout and distribution may reﬂect
myocardial adrenergic derangement in patientswith congestive cardiomyopa-
thy. Circulation 1988;78:1192–9.
[9] YufuK, TakahashiN,OkadaN, ShinoharaT,NakagawaM,HaraM,YoshimatsuH,
Saikawa T. Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintig-
raphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic
patients without structural heart disease. Circ J 2012;76:399–404.
10] Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M,
Probstﬁeld JL, Yusuf S. Prognostic signiﬁcance of plasma norepinephrine in
patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
Circulation 1996;94:690–7.
11] Cohn JN, LevineTB,OlivariMT,GarbergV, LuraD, FrancisGS, SimonAB,Rector T.
Plasma norepinephrine as a guide to prognosis in patients with chronic con-
gestive heart failure. N Engl J Med 1984;311:819–23.
12] Rouleau JL, Packer M, Moyé L, de Champlain J, Bichet D, Klein M, Rouleau JR,
Sussex B, Arnold JM, Sestier F, Parker JO, McEwan P, Bernstein V, Cuddy
TE, Lamas G, et al. Prognostic value of neurohumoral activation in patients
with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol
1994;24:583–91.
13] Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K,
Sasaki A, SeinoY, Ito C, ShimaK,NonakaK, Kadowaki T. Report of the committee
on the classiﬁcation and diagnostic criteria of diabetes mellitus. Diabetes Res
Clin Pract 2002;55:65–85.
14] La Rovere MT, Bigger Jr JT, Marcus FI, Mortara A, Schwartz PJ. Baroreﬂex sen-
sitivity and heart-rate variability in prediction of total cardiac mortality after
myocardial infarction. ATRAMI (Autonomic Tone andReﬂexesAfterMyocardial
Infarction) Investigators. Lancet 1998;351:478–84.
15] Liao D, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW, Cai J,
Sharrett AR. Multiple metabolic syndrome is associated with lower heart rate
variability. The Atherosclerosis Risk in Communities Study. Diabetes Care
1998;21:2116–22.
16] Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, Kasagi F.
Serum uric acid concentration as a risk factor for cardiovascular mortality. J
Rheumatol 2005;32:906–12.
17] National Kidney Foundation K/DOQI clinical practice guidelines for chronic
kidney disease: evaluation, classiﬁcation, and stratiﬁcation. Am J Kidney Dis
2002;39:S1–266.
18] Nagamachi S, Jinnouchi S, Kurose T, Ohnishi T, Flores 2nd LG, Nakahara H,
Futami S, Tamura S, Matsukura S. 123I-MIBG myocardial scintigraphy in dia-
betic patients: relationship with 201Tl uptake and cardiac autonomic function.
Ann Nucl Med 1998;12:323–31.
19] Murozono Y, Yufu K, Takahashi N, Okada N, Shinohara T, Nakagawa M, Hara M,
Saikawa T. Combined assessment of baroreﬂex sensitivity with iodine 123
metaiodobenzylguanidine scintigraphic ﬁndings strengthens the power of pre-
dictive value for cerebral and cardiovascular events in type 2 diabetic patients.
Circ J 2012;77:130–6.20] Sakata K, Shirotani M, Yoshida H, Kurata C. Cardiac sympathetic nervous
system in early essential hypertension assessed by 123I-MIBG. J Nucl Med
1999;40:6–11.
21] Cohn JN. Mechanisms in heart failure and the role of angiotensin-converting









[30 K. Yufu et al. / Journal of
22] Francis GS, McDonald KM, Cohn JN. Neurohumoral activation in preclin-
ical heart failure. Remolding and the potential for intervention. Circulation
1993;87:IV90–6.
23] Benedict CR. Neurohumoral aspects of heart failure. Cardiol Clin North Am
1994;12:9–23.
24] Martin EA, Prasad A, Rihal CS, Lerman LO, Lerman A. Endothelial function and
vascular response tomental stress are impaired in patientswith apical balloon-
ing syndrome. J Am Coll Cardiol 2010;56:1840–6.
25] Watanabe S, Amiya E, Watanabe M, Takata M, Ozeki A, Watanabe A,
Kawarasaki S, Nakao T, Hosoya Y, Omori K, Maemura K, Komuro I, Nagai
R. Simultaneous heart rate variability monitoring enhances the predictive
value of ﬂow-mediated dilation in ischemic heart disease. Circ J 2013;77:
1018–25.
26] Hori M, Okamoto H. Heart rate as a target of treatment of chronic heart failure.
J Cardiol 2012;60:86–90.
[logy 64 (2014) 225–230
27] Takahama H, Yokoyama H, Kada A, Sekiguchi K, Fujino M, Funada A, Amaki M,
Hasegawa T, Asakura M, Kanzaki H, Anzai T, Kitakaze M. Extent of heart rate
reduction during hospitalization using beta-blockers, not the achieved heart
rate itself at discharge, predicts the clinical outcome in patients with acute
heart failure syndromes. J Cardiol 2013;61:58–64.
28] Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease
associated with diabetes in men and women: meta-analysis of 37 prospective
cohort studies. BMJ 2006;332:73–8.
29] Yufu K, Takahashi N, Okada N, Wakisaka O, Shinohara T, Nakagawa M, Hara M,
Yoshimatsu H, Saikawa T. Gender difference in baroreﬂex sensitivity to pre-
dict cardiac and cerebrovascular events in type 2 diabetic patients. Circ J
2011;75:1418–23.
30] Kinugawa T, Ogino K, Osaki S, Kato M, Igawa O, Hisatome I, Fujita M,
Shigemasa C. Prognostic signiﬁcance of exercise plasma noradrenaline levels
for cardiac death in patients with mild heart failure. Circ J 2002;66:261–6.
